First Trust Advisors
BNTX icon

First Trust Advisors’s BioNTech BNTX Stock Holding History

First Trust Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.6M Sell
791,469
-48,522
-6% -$4.57M 0.04% 476
2026
Q1 		$74.7M Buy
839,991
+451,124
+116% +$46.4M 0.05% 434
2025
Q4 		$37M Buy
388,867
+83,245
+27% +$8.39M 0.03% 696
2025
Q3 		$30.1M Sell
305,622
-25,738
-8% -$2.75M 0.02% 762
2025
Q2 		$35.3M Buy
331,360
+14,425
+5% +$1.46M 0.03% 711
2025
Q1 		$28.9M Sell
316,935
-30,753
-9% -$3.44M 0.03% 747
2024
Q4 		$39.6M Sell
347,688
-103,504
-23% -$11.8M 0.03% 627
2024
Q3 		$53.6M Buy
451,192
+42,139
+10% +$3.87M 0.05% 474
2024
Q2 		$32.9M Buy
+409,053
New +$37.4M 0.03% 622
2024
Q1 		– Sell
-416,891
Closed -$44M – 2338
2023
Q4 		$44M Sell
416,891
-2,419
-0.6% -$244K 0.05% 463
2023
Q3 		$45.6M Buy
419,310
+10,895
+3% +$1.2M 0.05% 444
2023
Q2 		$44.1M Buy
408,415
+47,760
+13% +$5.37M 0.05% 480
2023
Q1 		$44.9M Buy
360,655
+8,393
+2% +$1.15M 0.05% 466
2022
Q4 		$52.9M Buy
352,262
+76,552
+28% +$11.8M 0.06% 439
2022
Q3 		$37.2M Sell
275,710
-40,834
-13% -$6.24M 0.05% 499
2022
Q2 		$47.2M Sell
316,544
-173,407
-35% -$26.5M 0.06% 455
2022
Q1 		$83.6M Buy
489,951
+187,569
+62% +$31.5M 0.09% 314
2021
Q4 		$78M Sell
302,382
-67,227
-18% -$18.4M 0.08% 327
2021
Q3 		$101M Buy
369,609
+268,440
+265% +$85.3M 0.11% 235
2021
Q2 		$22.6M Sell
101,169
-41,889
-29% -$7.9M 0.02% 726
2021
Q1 		$15.6M Buy
+143,058
New +$15.2M 0.02% 797

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

First Trust Advisors's BNTX Position: Q2 2026 in Review

First Trust Advisors reduced its BioNTech (BNTX) stake by 5.8% in Q2 2026, selling an estimated $4.57M and leaving 791,469 shares worth $73.6M. The position accounts for 0.04% of the portfolio, ranked #476.

First Trust Advisors first reported a position in BNTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $101M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • First Trust Advisors held 791,469 shares of BioNTech worth $73.6M as of Q2 2026.
  • First Trust Advisors sold 48,522 BioNTech shares in Q2 2026, an estimated $4.57M.
  • BioNTech made up 0.04% of First Trust Advisors's portfolio in Q2 2026, its #476 holding.
  • First Trust Advisors first reported a position in BioNTech in Q1 2021 and has held it in 21 quarters since.
  • First Trust Advisors's BioNTech position peaked at $101M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.